KPTI

$9.30+0.53 (+6.04%)

Market ClosedLast close May 4

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

No data available for this range. Intraday data may be limited by the exchange.

Loading stock data…